malondialdehyde has been researched along with Psychotic Disorders in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (50.00) | 24.3611 |
2020's | 3 (30.00) | 2.80 |
Authors | Studies |
---|---|
Carvalho, AF; Kanchanatawan, B; Maes, M; Sirivichayakul, S | 1 |
Bryll, A; Karcz, P; Kozicz, T; Krzyściak, W; Pilecki, M; Popiela, TJ; Skrzypek, J; Śmierciak, N; Szwajca, M | 1 |
Ayadi, F; Ben Thabet, J; Charfi, N; Grayaa, S; Guidara, W; Maalej, M; Messedi, M; Naifar, M; Omri, S | 1 |
Dhingra, S; Jindal, DK; Parle, M; Yadav, M | 1 |
Akyol, O; Kus, I; Ozyurt, B; Ozyurt, H; Sarsilmaz, M; Songur, A | 1 |
Acikgoz, HE; Akkaya, C; Dirican, M; Eker, SS; Sarandol, A; Sarandol, E | 1 |
Copoglu, US; Dokuyucu, R; Erbas, O; Inanir, A; Inanir, S; Kokacya, H | 1 |
Araújo, FY; Carvalho, AF; Gomes, PX; Macêdo, DS; Oliveira, GV; Sousa, FC; Souza, CM; Vasconcelos, SM; Viana, GS | 1 |
Gangadhar, BN; Janakiramaiah, N; Pai, BN; Ravindranath, V | 1 |
Correnti, EE; Mahadik, JS; Mahadik, SP; Mukherjee, S; Scheffer, R | 1 |
1 trial(s) available for malondialdehyde and Psychotic Disorders
Article | Year |
---|---|
Elevated plasma lipid peroxides at the onset of nonaffective psychosis.
Topics: Adult; Female; Glutathione Peroxidase; Humans; Lipid Peroxidation; Lipid Peroxides; Male; Malondialdehyde; Psychiatric Status Rating Scales; Psychotic Disorders; Schizoid Personality Disorder; Schizophrenia; Thiobarbituric Acid Reactive Substances | 1998 |
9 other study(ies) available for malondialdehyde and Psychotic Disorders
Article | Year |
---|---|
In schizophrenia, psychomotor retardation is associated with executive and memory impairments, negative and psychotic symptoms, neurotoxic immune products and lower natural IgM to malondialdehyde.
Topics: Humans; Immunoglobulin M; Malondialdehyde; Memory Disorders; Neuropsychological Tests; Psychotic Disorders; Schizophrenia | 2020 |
The Relationship between the Level of Anterior Cingulate Cortex Metabolites, Brain-Periphery Redox Imbalance, and the Clinical State of Patients with Schizophrenia and Personality Disorders.
Topics: Adult; Antioxidants; Aspartic Acid; Female; Glutamic Acid; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Malondialdehyde; Oxidants; Oxidation-Reduction; Oxidative Stress; Personality Disorders; Prognosis; Psychotic Disorders; Schizophrenia; Young Adult | 2020 |
Predictive value of oxidative stress biomarkers in drug‑free patients with schizophrenia and schizo-affective disorder.
Topics: Adult; Advanced Oxidation Protein Products; Biomarkers; Case-Control Studies; Female; Glutathione; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Middle Aged; Mood Disorders; Oxidation-Reduction; Oxidative Stress; Psychotic Disorders; ROC Curve; Schizophrenia; Sensitivity and Specificity; Tunisia | 2020 |
Protective effects of stigmasterol against ketamine-induced psychotic symptoms: Possible behavioral, biochemical and histopathological changes in mice.
Topics: Acetylcholine; Animals; Antipsychotic Agents; Brain; Catalepsy; Disease Models, Animal; Dopamine; gamma-Aminobutyric Acid; Glutathione; Ketamine; Male; Malondialdehyde; Mice; Motor Activity; Oxidative Stress; Protective Agents; Psychotic Disorders; Stigmasterol; Tumor Necrosis Factor-alpha | 2018 |
Potential role of some oxidant/antioxidant status parameters in prefrontal cortex of rat brain in an experimental psychosis model and the protective effects of melatonin.
Topics: Animals; Antioxidants; Disease Models, Animal; Dizocilpine Maleate; Glutathione Peroxidase; Male; Malondialdehyde; Melatonin; Oxidants; Oxidative Stress; Prefrontal Cortex; Psychotic Disorders; Rats; Rats, Wistar; Reactive Oxygen Species; Schizophrenia; Superoxide Dismutase | 2014 |
First-episode psychosis is associated with oxidative stress: Effects of short-term antipsychotic treatment.
Topics: Adult; Antipsychotic Agents; Apolipoprotein B-100; Aryldialkylphosphatase; Bilirubin; Carboxylic Ester Hydrolases; Case-Control Studies; Erythrocytes; Female; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Oxidation-Reduction; Oxidative Stress; Psychotic Disorders; Serum Albumin; Serum Albumin, Human; Superoxide Dismutase; Uric Acid; Vitamin E; Young Adult | 2015 |
Agomelatine Protection in an LPS-Induced Psychosis-Relevant Behavior Model.
Topics: Acetamides; Animals; Brain; Lipopolysaccharides; Male; Malondialdehyde; Melatonin; Psychotic Disorders; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2015 |
B vitamins attenuate haloperidol-induced orofacial dyskinesia in rats: possible involvement of antioxidant mechanisms.
Topics: Animals; Antioxidants; Antipsychotic Agents; Behavior, Animal; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Glutathione; Haloperidol; Lipid Peroxidation; Male; Malondialdehyde; Movement Disorders; Oxidative Stress; Psychotic Disorders; Rats; Rats, Wistar; Superoxide Dismutase; Vitamin B Complex | 2011 |
Depletion of glutathione and enhanced lipid peroxidation in the CSF of acute psychotics following haloperidol administration.
Topics: Administration, Oral; Adolescent; Adult; Female; Glutathione; Haloperidol; Humans; Lipid Peroxidation; Male; Malondialdehyde; Psychiatric Status Rating Scales; Psychotic Disorders | 1994 |